Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-23-000028

Options or other derivatives

  • Chief Scientific Officer acquired 157,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Carter Laura Chief Scientific Officer 2023-03-20 Grant or award · Stock Option (Right to Buy) +157,500 157,500 D: show line 1 in the form
Loading xslF345X04/wf-form4_167952019155286.xml…